Submit a late-breaking abstract through March 14! Send us your research that is high impact, groundbreaking, innovative, and newsworthy!
The first quarterly report of 2023 from ASGCT and Citeline is available now! The Gene, Cell, & RNA Therapy Landscape report is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.
Highlights from this issue include:
An mRNA vaccine was approved for COVID-19 prophylaxis in China
Vyznova, a non-genetically modified cell therapy, was approved for corneal dystrophy in Japan
Hemgenix was approved for hemophilia B in the EU and UK
Download the full report
May 13-17, 2025 | New Orleans
© 2000-2025 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico